{"id":"556597-8201","orgnr":"556597-8201","name":"Alligator Bioscience AB","name_registered_on":"2002-03-04","legal_form":{"code":"AB","name":"Aktiebolag"},"status":"registered","registered_on":"2000-09-21","business_description":"Bolaget skall direkt eller genom dotterbolag eller andra intressebolag, bedriva forsknings- och utvecklingsarbete samt tillverkning och handel inom proteinkemiområdet jämte med detta förenlig verksamhet.","industries":[{"code":"72109","name":"Annan naturvetenskaplig och teknisk forskning och utveckling"}],"postal_address":{"street":"Scheeletorget 1","care_of":"c/o Medicon Village","postal_code":"22381","city":"LUND","country":"SE","municipality":{"code":"1281","name":"Lund"},"county":{"code":"12","name":"Skåne län"}},"registered_office":{"municipality":{"code":"1281","name":"Lund"},"county":{"code":"12","name":"Skåne län"}},"activity_status":"active","employee_class":{"code":"4","name":"10-19 anställda"},"turnover_class":{"code":"4","name":"5 000 - 9 999 tkr","year":2025},"public_company":{"code":"23","name":"Publikt, Stockholm Small Cap"},"f_tax":"registered","vat":"registered","employer":"registered","registry_source":{"dataset":"bolagsverket_bulkfil","published_on":"2026-11-09"},"annual_reports":[{"from":"2025-01-01","to":"2025-12-31","framework":"IFRS","documents":{},"source":{"dataset":"esef","file":"/549300E15VI0MB7LXV19/2025-12-31/ESEF/SE/0/549300E15VI0MB7LXV19-2025-12-31.zip","url":"https://filings.xbrl.org/549300E15VI0MB7LXV19/2025-12-31/ESEF/SE/0/549300E15VI0MB7LXV19-2025-12-31-1-sv/reports/ixbrlviewer.html"}},{"from":"2024-01-01","to":"2024-12-31","framework":"IFRS","documents":{},"source":{"dataset":"esef","file":"/549300E15VI0MB7LXV19/2024-12-31/ESEF/SE/0/549300E15VI0MB7LXV19-2024-12-31-0-sv.zip","url":"https://filings.xbrl.org/549300E15VI0MB7LXV19/2024-12-31/ESEF/SE/0/549300E15VI0MB7LXV19-2024-12-31-0-sv/reports/ixbrlviewer.html"}},{"from":"2023-01-01","to":"2023-12-31","framework":"IFRS","documents":{},"source":{"dataset":"esef","file":"/549300E15VI0MB7LXV19/2023-12-31/ESEF/SE/0/549300E15VI0MB7LXV19-2023-12-31-sv.zip","url":"https://filings.xbrl.org/549300E15VI0MB7LXV19/2023-12-31/ESEF/SE/0/549300E15VI0MB7LXV19-2023-12-31-sv/reports/ixbrlviewer.html"}},{"from":"2022-01-01","to":"2022-12-31","framework":"IFRS","documents":{},"source":{"dataset":"esef","file":"/549300E15VI0MB7LXV19/2022-12-31/ESEF/SE/0/549300E15VI0MB7LXV19-2022-12-31-sv.zip","url":"https://filings.xbrl.org/549300E15VI0MB7LXV19/2022-12-31/ESEF/SE/0/549300E15VI0MB7LXV19-2022-12-31-sv/reports/ixbrlviewer.html"}},{"from":"2021-01-01","to":"2021-12-31","framework":"IFRS","documents":{},"source":{"dataset":"esef","file":"/549300E15VI0MB7LXV19/2021-12-31/ESEF/SE/0/549300E15VI0MB7LXV19-2021-12-31-sv.zip","url":"https://filings.xbrl.org/549300E15VI0MB7LXV19/2021-12-31/ESEF/SE/0/549300E15VI0MB7LXV19-2021-12-31-sv/reports/ixbrlviewer.html"}}],"latest_financials":{"from":"2025-01-01","to":"2025-12-31","scope":"group","currency":"SEK","net_sales":514000,"operating_profit":-105826000,"profit_after_financial_items":-51350000,"net_profit":-51350000,"total_assets":110603000,"equity":6859000,"long_term_liabilities":25599000,"current_liabilities":78145000,"cash":62198000,"staff_costs":43294000,"net_sales_growth":-0.991,"source":{"annual_report":"2025-12-31","document":"https://filings.xbrl.org/549300E15VI0MB7LXV19/2025-12-31/ESEF/SE/0/549300E15VI0MB7LXV19-2025-12-31-1-sv/reports/ixbrlviewer.html"},"anchors":{"cash":{"fact":"f0__s3__5__16"},"current_liabilities":{"fact":"f0__s3__5__37"},"equity":{"fact":"f0__s3__5__26"},"long_term_liabilities":{"fact":"f0__s3__5__30"},"net_profit":{"fact":"f0__s1__3__19"},"net_sales":{"fact":"f0__s1__3__5"},"operating_profit":{"fact":"f0__s1__3__13"},"profit_after_financial_items":{"fact":"f0__s1__3__17"},"staff_costs":{"fact":"f0__s1__3__9"},"total_assets":{"fact":"f0__s3__5__20"}}}}